Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Nuclear Medicine Communications|August 9, 2021
Efficacy of 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting response to second-generation androgen receptor axis-targeted therapy, and the prognosis in metastatic hormone-refractory prostate cancer patientsZeynep Oruç, Yunus Güzel, Senar Ebinç, et al.Contemporary Oncology (Poznan, Poland)|November 29, 2017
The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusionYakup Düzköprü, Zeynep Oruç, Muhammet A Kaplan, et al.Nuclear Medicine Communications|October 18, 2021
Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinomaCihan Gündoğan, Halil Kömek, Canan Can, et al.Annali Italiani Di Chirurgia|December 26, 2024
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast CancerZuhat Urakçı, Muhammet Ali Kaplan, Zeynep Oruç, et al.Annals of Nuclear Medicine|May 2, 2021
68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CTHalil Kömek, Canan Can, Yunus Güzel, et al.Future Oncology (London, England)|September 7, 2022
Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapySenar Ebinç, Zeynep Oruç, Yasin Sezgin, et al.Nuclear Medicine Communications|November 28, 2022
18 F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancerSenar Ebinç, Yunus Güzel, Zeynep Oruç, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 19, 2020
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective studySinan Koca, Mehmet Beşiroğlu, Melike Özçelik, et al.Future Oncology (London, England)|February 26, 2021
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastasesZeynep Oruç, M Ali Kaplan, Mustafa Karaağaç, et al.Cancers|July 28, 2026
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant ChemotherapyNeslihan Özyurt, Ali Alkan, Burcu Gülbağcı, et al.Pageof 3